PROPERTIES AND FUNCTIONS OF THE NOVEL TYPE I INTERFERON EPSILON

Zoe R. C. Marks(Hudson Institute of Medical Research), Paul J. Hertzog(Hudson Institute of Medical Research), Linden J. Gearing(Hudson Institute of Medical Research), Nollaig M. Bourke(Trinity College Dublin), San Sui Lim(Hudson Institute of Medical Research), Nicole A. de Weerd(Monash Health), Nicole K. Campbell(Hudson Institute of Medical Research)
Seminars in Immunology
June 1, 2019
10.1016/j.smim.2019.101328
Cited by 40

Related Papers

Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2
|Journal of Biological Chemistry|2011|160
Interferon-ε is a tumour suppressor and restricts ovarian cancer
|Nature|2023|70
A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling
|Journal of Biological Chemistry|2017|25
Spatiotemporal regulation of human IFN-ε and innate immunity in the female reproductive tract
|JCI Insight|2022|25
Investigation of type I interferon and immune signalling in breast and ovarian cancer
|Journal and proceedings of the Royal Society of New South Wales|2018|0